US5874261A
(en)
*
|
1988-09-02 |
1999-02-23 |
The Trustees Of The University Of Pennsylvania |
Method for the purification of glycosyltransferases
|
DE4009630C2
(de)
*
|
1990-03-26 |
1995-09-28 |
Reinhard Prof Dr Dr Brossmer |
CMP-aktivierte fluoreszierende Sialinsäuren sowie Verfahren zu ihrer Herstellung
|
US5180674A
(en)
|
1990-04-16 |
1993-01-19 |
The Trustees Of The University Of Pennsylvania |
Saccharide compositions, methods and apparatus for their synthesis
|
US5583042A
(en)
*
|
1990-04-16 |
1996-12-10 |
Neose Pharmaceuticals, Inc. |
Apparatus for the synthesis of saccharide compositions
|
CA2106301C
(en)
|
1991-03-18 |
1999-04-06 |
Chi-Huey Wong |
Oligosaccharide enzyme substrates and inhibitors: method and compositions
|
US5461143A
(en)
*
|
1991-03-18 |
1995-10-24 |
The Scripps Research Institute |
Oligosaccharide enzyme substrates and inhibitors: methods and compositions
|
US5278299A
(en)
*
|
1991-03-18 |
1994-01-11 |
Scripps Clinic And Research Foundation |
Method and composition for synthesizing sialylated glycosyl compounds
|
US6518051B1
(en)
*
|
1991-04-11 |
2003-02-11 |
The Trustees Of The University Of Pennsylvania |
Saccharide compositions, methods and apparatus for their synthesis
|
JPH06506830A
(ja)
*
|
1991-05-07 |
1994-08-04 |
オックスフォード・グリコシステムズ・リミテッド |
オリゴ糖の配列決定
|
US5646123A
(en)
*
|
1991-06-10 |
1997-07-08 |
Alberta Research Council |
Time dependent administration of oligosaccharide glycosides related to blood group determinants having a type I or type II core structure in reducing inflammation in a sensitized mammal arising form exposure to an antigen
|
US5403726A
(en)
*
|
1991-07-30 |
1995-04-04 |
The Scripps Research Institute |
Enzymatic process for producing a galactosylβ1,3glycal disaccaride using β-galactosidase
|
CA2121365C
(en)
|
1991-10-15 |
2000-11-28 |
Chi-Huey Wong |
Production of fucosylated carbohydrates by enzymatic fucosylation synthesis of sugar nucleotides; and in situ regeneration of gdp-fucose
|
US6319695B1
(en)
*
|
1991-10-15 |
2001-11-20 |
The Scripps Research Insitute |
Production of fucosylated carbohydrates by enzymatic fucosylation synthesis of sugar nucleotides; and in situ regeneration of GDP-fucose
|
GB9207182D0
(en)
*
|
1992-04-01 |
1992-05-13 |
Enzymatix Ltd |
Glycolipids and their preparation
|
US5438130A
(en)
*
|
1993-01-15 |
1995-08-01 |
Cambridge Neuroscience, Inc. |
Fucosylated guanosine disulfates as excitatory amino acid antagonists
|
CA2157489A1
(en)
*
|
1993-03-04 |
1994-09-15 |
Masaaki Numata |
Lewis-associated compound, process for producing the same, and anti-inflammatory
|
US5374541A
(en)
*
|
1993-05-04 |
1994-12-20 |
The Scripps Research Institute |
Combined use of β-galactosidase and sialyltransferase coupled with in situ regeneration of CMP-sialic acid for one pot synthesis of oligosaccharides
|
US5409817A
(en)
*
|
1993-05-04 |
1995-04-25 |
Cytel, Inc. |
Use of trans-sialidase and sialyltransferase for synthesis of sialylα2→3βgalactosides
|
CN1129953A
(zh)
*
|
1993-07-15 |
1996-08-28 |
尼奥斯药品公司 |
糖组分的合成方法
|
US5559103A
(en)
*
|
1993-07-21 |
1996-09-24 |
Cytel Corporation |
Bivalent sialyl X saccharides
|
US5472859A
(en)
*
|
1993-08-02 |
1995-12-05 |
Brown, Jr.; R. Malcolm |
Enzymatic method for synthesis of cellulose 1
|
DE4330773A1
(de)
*
|
1993-09-10 |
1995-03-16 |
Laevosan Gmbh & Co Kg |
Blockierung der Anlagerung von Keimen an menschliche Zellen
|
US5516665A
(en)
*
|
1993-09-13 |
1996-05-14 |
The Scripps Research Institute |
N-acetylgalactosaminyl or N-acetylglucosaminyl transfer using N-acetylglucosaminyl-1-phosphate or N-acetylgalactosaminyl-1-phosphate as precursor and glycosyl-nucleotide regeneration
|
US6485930B1
(en)
|
1993-09-15 |
2002-11-26 |
The Scripps Research Institute |
Mannosyl transfer with regeneration of GDP-mannose
|
US5616698A
(en)
*
|
1994-01-10 |
1997-04-01 |
University Of Toronto Innovations Foundation |
Polymer-supported solution synthesis of oligosaccharides
|
US5369017A
(en)
*
|
1994-02-04 |
1994-11-29 |
The Scripps Research Institute |
Process for solid phase glycopeptide synthesis
|
US5750176A
(en)
*
|
1994-03-09 |
1998-05-12 |
Abbott Laboratories |
Transgenic non-human mammal milk comprising 2'-fucosyl-lactose
|
NZ279676A
(en)
*
|
1994-03-09 |
1998-04-27 |
Abbott Lab |
Humanized milk produced by non-human transgenic mammal transformed with a heterologous gene coding for human enzyme producing human oligosaccharides and glycoconjugates
|
EP0750671A1
(en)
*
|
1994-03-09 |
1997-01-02 |
Abbott Laboratories |
Transgenic animals producing oligosaccharides and glycoconjugates
|
US6204431B1
(en)
|
1994-03-09 |
2001-03-20 |
Abbott Laboratories |
Transgenic non-human mammals expressing heterologous glycosyltransferase DNA sequences produce oligosaccharides and glycoproteins in their milk
|
US5665561A
(en)
*
|
1994-06-06 |
1997-09-09 |
The Rockefeller University |
Modulators of pneumococcal adherence to pulmonary and vascular cells and diagnostic and therapeutic applications
|
US5545553A
(en)
|
1994-09-26 |
1996-08-13 |
The Rockefeller University |
Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
|
US5834251A
(en)
*
|
1994-12-30 |
1998-11-10 |
Alko Group Ltd. |
Methods of modifying carbohydrate moieties
|
US5728554A
(en)
*
|
1995-04-11 |
1998-03-17 |
Cytel Corporation |
Enzymatic synthesis of glycosidic linkages
|
US5922577A
(en)
*
|
1995-04-11 |
1999-07-13 |
Cytel Corporation |
Enzymatic synthesis of glycosidic linkages
|
US5876980A
(en)
*
|
1995-04-11 |
1999-03-02 |
Cytel Corporation |
Enzymatic synthesis of oligosaccharides
|
US6030815A
(en)
*
|
1995-04-11 |
2000-02-29 |
Neose Technologies, Inc. |
Enzymatic synthesis of oligosaccharides
|
US6127153A
(en)
*
|
1995-06-07 |
2000-10-03 |
Neose Technologies, Inc. |
Method of transferring at least two saccharide units with a polyglycosyltransferase, a polyglycosyltransferase and gene encoding a polyglycosyltransferase
|
JP4023848B2
(ja)
*
|
1996-03-29 |
2007-12-19 |
生化学工業株式会社 |
硫酸化ラクトサミンオリゴ糖の製造方法
|
US6033663A
(en)
*
|
1996-04-10 |
2000-03-07 |
Neose Technologies, Inc. |
Nucleic acids encoding GDP-Fucose pyrophosphorylase
|
US5906982A
(en)
*
|
1997-03-31 |
1999-05-25 |
Abbott Laboratories |
Nutritional formulations containing Lacto-N-neoTetraose
|
US6045854A
(en)
*
|
1997-03-31 |
2000-04-04 |
Abbott Laboraties |
Nutritional formulations containing oligosaccharides
|
US5945314A
(en)
*
|
1997-03-31 |
1999-08-31 |
Abbott Laboratories |
Process for synthesizing oligosaccharides
|
DE19716731A1
(de)
*
|
1997-04-14 |
1998-10-15 |
Biopract Gmbh |
Verfahren zur enzymatischen Herstellung von Fructosylverbindungen
|
US6433161B1
(en)
|
1997-04-29 |
2002-08-13 |
Hercules Incorporated |
Galactosylated hydroxyalkyl polysaccharides
|
US20040191256A1
(en)
*
|
1997-06-24 |
2004-09-30 |
Genentech, Inc. |
Methods and compositions for galactosylated glycoproteins
|
AU757627B2
(en)
|
1997-06-24 |
2003-02-27 |
Genentech Inc. |
Methods and compositions for galactosylated glycoproteins
|
JP4003093B2
(ja)
*
|
1997-07-29 |
2007-11-07 |
東洋紡績株式会社 |
糖類の製造方法
|
US20030027262A1
(en)
*
|
1997-09-18 |
2003-02-06 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US6368604B1
(en)
|
1997-09-26 |
2002-04-09 |
University Of Maryland Biotechnology Institute |
Non-pyrogenic derivatives of lipid A
|
US20040136986A1
(en)
*
|
1997-10-31 |
2004-07-15 |
Genentech, Inc. |
Methods and compositions comprising glycoprotein glycoforms
|
ATE419009T1
(de)
|
1997-10-31 |
2009-01-15 |
Genentech Inc |
Methoden und zusammensetzungen bestehend aus glykoprotein-glykoformen
|
DE69841740D1
(de)
*
|
1998-01-22 |
2010-08-05 |
Mitsubishi Electric Corp |
Batterie
|
US7094943B2
(en)
|
1998-04-27 |
2006-08-22 |
Hubert Köster |
Solution phase biopolymer synthesis
|
US6423833B1
(en)
|
1998-05-05 |
2002-07-23 |
Steven J. Catani |
Functional sugar polymers from inexpensive sugar sources and apparatus for preparing same
|
US7223845B2
(en)
|
1998-06-16 |
2007-05-29 |
The Board Of Regents Of The University Of Oklahoma |
Synthetic glycosulfopeptides and methods of synthesis thereof
|
CA2332563A1
(en)
|
1998-06-16 |
1999-12-23 |
The Board Of Regents Of The University Of Oklahoma |
Glycosulfopeptides and methods of synthesis and use thereof
|
US20030143662A1
(en)
|
1998-06-16 |
2003-07-31 |
Cummings Richard D. |
Glycosulfopeptide inhibitors of leukocyte rolling and methods of use thereof
|
US7339033B2
(en)
*
|
1998-06-26 |
2008-03-04 |
Genentech, Inc. |
Pro1481
|
US6596477B1
(en)
|
1998-09-28 |
2003-07-22 |
University Of Maryland Biotechnology Institute |
Treatment and prevention of immunodeficiency virus infection by administration of non-pyrogenic derivatives of lipid A
|
EP2264177B1
(en)
*
|
1998-12-09 |
2015-09-30 |
Phyton Holdings, LLC |
Glycoproteins having human-type glycosylation
|
US20010051349A1
(en)
|
2000-02-17 |
2001-12-13 |
Glycominds Ltd. |
Combinatorial complex carbohydrate libraries and methods for the manufacture and uses thereof
|
US20030059915A1
(en)
*
|
1999-06-15 |
2003-03-27 |
Canfield William M. |
Core 1 beta3-galactosyl transferases and methods of use thereof
|
US6492152B1
(en)
|
1999-06-15 |
2002-12-10 |
The Board Of Regents Of The University Of Oklahoma |
Core 1 β3-galactosyl transferases and methods of use thereof
|
US20030235884A1
(en)
*
|
1999-06-15 |
2003-12-25 |
Cummings Richard D. |
Polynucleotides encoding core 1 beta3-galactosyl transferase and methods of use thereof
|
AU1431101A
(en)
|
1999-10-04 |
2001-05-10 |
University Of Maryland Biotechnology Institute |
Novel adjuvant comprising a lipopolysaccharide antagonist
|
JP4890712B2
(ja)
*
|
1999-10-26 |
2012-03-07 |
スティヒティング ディーンスト ランドバウクンディフ オンデルズーク |
植物における哺乳類型グリコシレーション
|
US20020098513A1
(en)
*
|
2000-02-17 |
2002-07-25 |
Glycominds Ltd. |
Combinatorial complex carbohydrate libraries and methods for the manufacture and uses thereof
|
US6586207B2
(en)
*
|
2000-05-26 |
2003-07-01 |
California Institute Of Technology |
Overexpression of aminoacyl-tRNA synthetases for efficient production of engineered proteins containing amino acid analogues
|
US20020132320A1
(en)
*
|
2001-01-10 |
2002-09-19 |
Wang Peng George |
Glycoconjugate synthesis using a pathway-engineered organism
|
CN100385006C
(zh)
|
2001-01-19 |
2008-04-30 |
陶氏化学公司 |
利用植物细胞分泌性生产具有人型糖链的糖蛋白的方法
|
BR0207857A
(pt)
*
|
2001-03-06 |
2004-03-23 |
Dow Chemical Co |
Célula de planta tendo uma função de adição de açúcar do tipo animal
|
US6596707B2
(en)
|
2001-05-24 |
2003-07-22 |
Abbott Laboratories |
Monovalent saccharides and uses thereof
|
WO2003004597A1
(fr)
*
|
2001-07-02 |
2003-01-16 |
Hitachi, Ltd. |
Dispositif de synthese de chaines glucidiques
|
AU2002326805B2
(en)
|
2001-08-29 |
2009-01-22 |
Seneb Biosciences, Inc. |
Novel synthetic ganglioside derivatives and compositions thereof
|
US7214660B2
(en)
*
|
2001-10-10 |
2007-05-08 |
Neose Technologies, Inc. |
Erythropoietin: remodeling and glycoconjugation of erythropoietin
|
AU2004236174B2
(en)
|
2001-10-10 |
2011-06-02 |
Novo Nordisk A/S |
Glycopegylation methods and proteins/peptides produced by the methods
|
US7173003B2
(en)
|
2001-10-10 |
2007-02-06 |
Neose Technologies, Inc. |
Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
|
EP2319935B1
(en)
*
|
2002-03-19 |
2016-04-27 |
Stichting Dienst Landbouwkundig Onderzoek |
GnTIII (UDP-N-acetylglucosamine:Beta -D mannoside Beta (1,4)-N-acetylglucosaminyltransferase III) expression in plants.
|
CA2478297C
(en)
*
|
2002-03-19 |
2013-05-14 |
Plant Research International B.V. |
Optimizing glycan processing in plants
|
US20040052915A1
(en)
*
|
2002-09-13 |
2004-03-18 |
Carlson Ting L. |
Use of low glycemic index sweeteners in food and beverage compositions
|
ES2333422T3
(es)
*
|
2002-10-16 |
2010-02-22 |
The Scripps Research Institute |
Sintesis de glicoproteinas.
|
JP4006385B2
(ja)
*
|
2002-11-20 |
2007-11-14 |
株式会社日立ハイテクノロジーズ |
糖鎖合成装置
|
AR042145A1
(es)
*
|
2002-11-27 |
2005-06-08 |
Dow Agrociences Llc |
Produccion de inmunoglobulinas en plantas con una fucocilacion reducida
|
AU2003299730B2
(en)
*
|
2002-12-20 |
2009-04-02 |
Momenta Pharmaceuticals, Inc. |
Glycan markers for diagnosing and monitoring disease
|
JP4405736B2
(ja)
|
2003-01-31 |
2010-01-27 |
コニカミノルタホールディングス株式会社 |
データベースシステム
|
US7309600B2
(en)
*
|
2003-02-12 |
2007-12-18 |
University Of Iowa Research Foundation |
Haemophilus influenzae sialyltransferase and methods of use thereof
|
NZ542148A
(en)
|
2003-03-06 |
2008-05-30 |
Neose Technologies Inc |
Methods and compositions for the enzymatic synthesis of gangliosides
|
US7951410B2
(en)
*
|
2003-04-14 |
2011-05-31 |
Mead Johnson Nutrition Company |
Enteral compositions containing caseinoglycomacropeptide having an enhanced concentration of sialic acid
|
US7867541B2
(en)
*
|
2003-04-14 |
2011-01-11 |
Mead Johnson Nutrition Company |
Compositions and methods of formulation for enteral formulas containing sialic acid
|
US7700701B2
(en)
|
2003-05-08 |
2010-04-20 |
Toyo Boseki Kabushiki Kaisha |
Water-soluble polymer compound having sugar chains
|
US9005625B2
(en)
|
2003-07-25 |
2015-04-14 |
Novo Nordisk A/S |
Antibody toxin conjugates
|
US7999003B2
(en)
|
2003-08-26 |
2011-08-16 |
Mannatech, Incorporated |
Antioxidant compositions and methods thereto
|
EP1680110B1
(en)
*
|
2003-11-04 |
2011-01-05 |
Supernus Pharmaceuticals, Inc. |
Once daily dosage forms of trospium
|
US20080305992A1
(en)
|
2003-11-24 |
2008-12-11 |
Neose Technologies, Inc. |
Glycopegylated erythropoietin
|
EP1729596A4
(en)
*
|
2004-03-17 |
2012-08-15 |
Cargill Inc |
SWEETENERS WITH LOW GLYCEMIC VALUE AND PRODUCTS MANUFACTURED THEREFOR
|
JP4252922B2
(ja)
*
|
2004-03-31 |
2009-04-08 |
株式会社日立ハイテクノロジーズ |
糖鎖合成装置
|
US20050287639A1
(en)
*
|
2004-05-17 |
2005-12-29 |
California Institute Of Technology |
Methods of incorporating amino acid analogs into proteins
|
US20080300173A1
(en)
|
2004-07-13 |
2008-12-04 |
Defrees Shawn |
Branched Peg Remodeling and Glycosylation of Glucagon-Like Peptides-1 [Glp-1]
|
WO2006030840A1
(ja)
*
|
2004-09-14 |
2006-03-23 |
National Institute Of Advanced Industrial Scienceand Technology |
ムチン型ペプチドの合成法とmuc1関連糖ペプチド
|
EP1809758A4
(en)
*
|
2004-10-20 |
2009-04-01 |
Scripps Research Inst |
LOCAL IN VIVO INSTALLATION OF N-ACETYLGALACTOSAMINE AMINO ACIDS IN EU BACTERIA
|
DK2586456T3
(en)
|
2004-10-29 |
2016-03-21 |
Ratiopharm Gmbh |
Conversion and glycopegylation of fibroblast growth factor (FGF)
|
EP1858543B1
(en)
*
|
2005-01-10 |
2013-11-27 |
BioGeneriX AG |
Glycopegylated granulocyte colony stimulating factor
|
BRPI0608080B1
(pt)
*
|
2005-02-15 |
2017-11-21 |
Cargill Incorporated |
Processes for manufacture of syrup and food or drink, syrup and composition of food or drink
|
EP2386571B1
(en)
*
|
2005-04-08 |
2016-06-01 |
ratiopharm GmbH |
Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
|
TWI264608B
(en)
*
|
2005-04-08 |
2006-10-21 |
Delta Electronics Inc |
Light tunnel module
|
US20070105755A1
(en)
*
|
2005-10-26 |
2007-05-10 |
Neose Technologies, Inc. |
One pot desialylation and glycopegylation of therapeutic peptides
|
CN102719508A
(zh)
*
|
2005-08-19 |
2012-10-10 |
诺和诺德公司 |
糖基聚乙二醇化的因子vii和因子viia
|
US20090048440A1
(en)
|
2005-11-03 |
2009-02-19 |
Neose Technologies, Inc. |
Nucleotide Sugar Purification Using Membranes
|
EP2444499A3
(en)
|
2006-05-02 |
2012-05-09 |
Allozyne, Inc. |
Amino acid substituted molecules
|
US7605255B2
(en)
|
2006-06-29 |
2009-10-20 |
Alberta Research Council Inc. |
Non-animal based lactose
|
EP2049144B8
(en)
*
|
2006-07-21 |
2015-02-18 |
ratiopharm GmbH |
Glycosylation of peptides via o-linked glycosylation sequences
|
US20100075375A1
(en)
*
|
2006-10-03 |
2010-03-25 |
Novo Nordisk A/S |
Methods for the purification of polypeptide conjugates
|
LT2068907T
(lt)
*
|
2006-10-04 |
2018-01-10 |
Novo Nordisk A/S |
Glicerolio sujungti pegilinti sacharidai ir glikopeptidai
|
CN101796063B
(zh)
*
|
2007-04-03 |
2017-03-22 |
拉蒂奥法姆有限责任公司 |
使用糖聚乙二醇化g‑csf的治疗方法
|
CA2684370C
(en)
|
2007-04-17 |
2017-10-17 |
Plant Research International B.V. |
Mammalian-type glycosylation in plants by expression of non-mammalian glycosyltransferases
|
ES2551123T3
(es)
|
2007-06-12 |
2015-11-16 |
Ratiopharm Gmbh |
Proceso mejorado para la producción de azúcares de nucleótido
|
PT2217246E
(pt)
*
|
2007-11-08 |
2015-02-10 |
Nestec Sa |
Utilização de oligossacáridos contendo n-acetil-lactosamina para maturação de respostas imunes em recém-nascidos
|
EP2060257A1
(en)
*
|
2007-11-08 |
2009-05-20 |
Nestec S.A. |
Prevention and treatment of secondary infections following viral infection
|
CA2711503A1
(en)
*
|
2008-01-08 |
2009-07-16 |
Biogenerix Ag |
Glycoconjugation of polypeptides using oligosaccharyltransferases
|
MX2010009154A
(es)
|
2008-02-27 |
2010-09-09 |
Novo Nordisk As |
Moleculas conjugadas del factor viii.
|
AU2009224814B2
(en)
|
2008-03-14 |
2015-02-05 |
Société des Produits Nestlé S.A. |
Synbiotic mixture
|
EP2347003B1
(en)
*
|
2008-10-29 |
2020-06-10 |
Janssen Biotech, Inc. |
Galactose alpha (1-3) galactose compositions
|
US20120035120A1
(en)
|
2009-03-25 |
2012-02-09 |
Seneb Biosciences, Inc. |
Glycolipids as treatment for disease
|
EP2640745B1
(en)
|
2010-09-10 |
2018-11-07 |
MedImmune Limited |
Bivalent and bispecific anti-il6/anti-il23 antibodies
|
EP2454948A1
(en)
|
2010-11-23 |
2012-05-23 |
Nestec S.A. |
Oligosaccharide mixture and food product comprising this mixture, especially infant formula
|
EP2465509A1
(en)
|
2010-11-23 |
2012-06-20 |
Nestec S.A. |
Oligosaccharide composition for treating acute respiratory tract infections
|
EP2465507A1
(en)
|
2010-11-23 |
2012-06-20 |
Nestec S.A. |
Oligosaccharide composition for treating skin diseases
|
EP2465508A1
(en)
|
2010-11-23 |
2012-06-20 |
Nestec S.A. |
Composition comprising hydrolysed proteins and oligosaccharides for treating skin diseases
|
EP2511289A1
(en)
*
|
2011-04-14 |
2012-10-17 |
Universität zu Köln |
Method for the rapid chemoenzymatic glycosylation of conjugates between peptides and hydrophilic polymers
|
PL2768312T3
(pl)
|
2011-10-18 |
2016-06-30 |
Nestec Sa |
Kompozycja do stosowania dla wspomagania zdrowego rozwoju oraz/albo w zapobieganiu oraz/albo w leczeniu chorób kości
|
RU2604503C2
(ru)
|
2011-10-18 |
2016-12-10 |
Нестек С.А. |
Композиция для применения при повышении чувствительности к инсулину и/или снижении инсулинорезистентности
|
US20140286908A1
(en)
|
2011-10-18 |
2014-09-25 |
Nestec S.A. |
Composition for use in the promotion of intestinal angiogenesis and of nutrient absorption and of enteral feeding tolerance and/or in the prevention and/or treatment of intestinal inflammation and/or in the recovery after intestinal injury and surgery
|
WO2013057072A1
(en)
|
2011-10-18 |
2013-04-25 |
Nestec S.A. |
Composition for use in the promotion of magnesium absorption and/or magnesium retention
|
PT2775852T
(pt)
|
2011-10-18 |
2016-11-08 |
Nestec Sa |
Composição para utilização no crescimento cerebral e/ou desenvolvimento cognitivo e/ou psicomotor
|
KR102155389B1
(ko)
|
2012-09-24 |
2020-09-11 |
메디뮨 리미티드 |
세포주
|
US20140115728A1
(en)
|
2012-10-24 |
2014-04-24 |
A. Joseph Tector |
Double knockout (gt/cmah-ko) pigs, organs and tissues
|
DK2769726T3
(en)
|
2013-02-21 |
2019-02-25 |
Jennewein Biotechnologie Gmbh |
Synthetic or recombinant fucosylated oligosaccharides for use in the treatment of infections
|
PT3111942T
(pt)
|
2013-11-15 |
2021-03-23 |
Nestle Sa |
Composições para utilização na prevenção ou tratamento de infecções do urt em lactentes ou crianças pequenas em risco
|
EP3071208B1
(en)
|
2013-11-15 |
2021-08-11 |
Société des Produits Nestlé S.A. |
Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants and young children
|
AU2014350156A1
(en)
|
2013-11-15 |
2016-04-14 |
Nestec S.A. |
Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants or young children born by C-section
|
US10709721B2
(en)
|
2015-03-05 |
2020-07-14 |
Societe Des Produits Nestle S.A. |
Compositions for use in the prevention or treatment of gastrointestinal infections/inflammations in infants or young children
|
WO2016139330A1
(en)
|
2015-03-05 |
2016-09-09 |
Nestec S.A. |
Compositions for use in improving stool consistency or frequency in infants or young children
|
RU2720201C2
(ru)
|
2015-03-05 |
2020-04-27 |
Сосьете Де Продюи Нестле С.А. |
Композиции для применения в профилактике или лечении отита или бронхита у младенцев или детей младшего возраста
|
US20190160082A1
(en)
|
2016-08-04 |
2019-05-30 |
Nestec S.A. |
Nutritional compositions with 2fl and lnnt for use in preventing and/or treating non-rotavirus diarrhea by acting on the gut microbiota dysbiosis
|
US11179405B2
(en)
|
2016-09-07 |
2021-11-23 |
Societe Des Produits Nestle S.A. |
Nutritional compositions for infants and/or young children comprising oligosaccharides
|
RU2769462C2
(ru)
|
2017-05-09 |
2022-03-31 |
Сосьете Де Продюи Нестле С.А. |
Синергетическая выработка бутирата, связанная со сложностью смеси огм для применения у младенцев или детей младшего возраста в медицинских целях
|
EP3629769A1
(en)
|
2017-05-24 |
2020-04-08 |
Société des Produits Nestlé S.A. |
Composition comprising human milk oligosaccharides (hmo) for use in the improvement of short term memory and other cognitive benefits
|
US20200108084A1
(en)
|
2017-05-24 |
2020-04-09 |
Societe Des Produits Nestle S.A. |
Composition comprising oligofructose (of) for use in the improvement of short term memory and other cognitive benefits
|
US11260067B2
(en)
|
2017-05-24 |
2022-03-01 |
Societe Des Produits Nestle S.A. |
Methods and compositions for decreasing concentrations of detrimental proteolytic metabolites, treating health disorders, and/or promoting health benefits in infants or young children
|
EP3727398A1
(en)
|
2017-12-21 |
2020-10-28 |
Société des Produits Nestlé S.A. |
Compositions comprising at least on n-acetylated and at least one fucosylated oligosaccharide for use in the promotion of digestive capacity in infants and young children
|
BR112020008724A2
(pt)
|
2017-12-21 |
2020-11-03 |
Société des Produits Nestlé S.A. |
composições para uso na promoção do crescimento e desenvolvimento do músculo intestinal e motilidade intestinal associada
|
EP3727038A1
(en)
|
2017-12-22 |
2020-10-28 |
Société des Produits Nestlé S.A. |
Compositions for use in the reduction of nociception in infants and young children
|
MX2020012783A
(es)
|
2018-06-25 |
2021-01-20 |
Nestle Sa |
Composicion que comprende oligosacaridos de la leche humana para uso en la mejora, refuerzo, promocion o modulacion de una funcion serotonergica en el sistema nervioso central.
|
BR112020023102A2
(pt)
|
2018-06-25 |
2021-02-02 |
Société des Produits Nestlé S.A. |
uso de oligossacarídeos de leite humano, e composição que compreende os mesmos
|
US20220000892A1
(en)
|
2018-11-30 |
2022-01-06 |
Societe Des Produits Nestle S.A. |
Infant nutritional composition for use in the enhancement of pancreatic maturation and insulin biosynthesis
|
US20220287349A1
(en)
|
2018-12-21 |
2022-09-15 |
Societe Des Produits Nestle S.A. |
A nutritional composition comprising 6'sl and lnt in combination to improve the gastrointestinal barrier function
|
DE202019005475U1
(de)
|
2018-12-21 |
2020-09-23 |
Société des Produits Nestlé S.A. |
Eine Nahrungsmittelzusammensetzung umfassend 2'-Fucosyllactose zur Verbesserung der gastrointestinalen Barriere
|
AU2019407214A1
(en)
|
2018-12-21 |
2021-06-10 |
Societe Des Produits Nestle S.A. |
A nutritional composition comprising metabolites of HMOs to improve the gastrointestinal barrier
|
US20220225627A1
(en)
|
2019-03-05 |
2022-07-21 |
Societe Des Produits Nestle S.A. |
A nutritional composition for use to enhance executive function
|
CA3153046A1
(en)
|
2019-10-17 |
2021-04-22 |
Societe Des Produits Nestle S.A. |
Infant formula
|
US20240138460A1
(en)
|
2019-10-17 |
2024-05-02 |
Societe Des Produits Nestle S.A. |
Extensively hydrolysed infant formula
|
MX2022006838A
(es)
|
2019-12-11 |
2022-07-11 |
Nestle Sa |
Composiciones para usar en la reduccion de la nocicepcion y otros beneficios para la salud en infantes y niños pequeños.
|
WO2021136751A1
(en)
|
2019-12-30 |
2021-07-08 |
Société des Produits Nestlé S.A. |
Infant formula
|
EP4192970A1
(en)
*
|
2020-08-10 |
2023-06-14 |
Inbiose N.V. |
Production of alpha-1,3 glycosylated form of fuc-a1,2-gal-r
|
AU2021359712A1
(en)
|
2020-10-16 |
2023-03-23 |
Société des Produits Nestlé S. A. |
Infant or young child formula
|
US20230381211A1
(en)
|
2020-10-16 |
2023-11-30 |
Societe Des Produits Nestle S.A. |
Nutritional composition comprising human milk oligosaccharides
|
US20240009216A1
(en)
|
2020-11-10 |
2024-01-11 |
Societe Des Produits Nestle S.A. |
Nutritional composition
|
MX2023006258A
(es)
|
2020-12-18 |
2023-06-12 |
Nestle Sa |
Composiciones para usar en la promocion de la produccion acelerada de butirato en ni?os peque?os.
|
US20240301345A1
(en)
|
2021-06-29 |
2024-09-12 |
The Broad Institute, Inc. |
Bifidobacterium longum transitional microorganisms, compositions and uses thereof
|
WO2023237306A1
(en)
|
2022-06-09 |
2023-12-14 |
Dsm Ip Assets B.V. |
Nutritional composition comprising gos and hmos
|
WO2024165630A1
(en)
|
2023-02-07 |
2024-08-15 |
N.V. Nutricia |
Nutritional composition with improved segregation resistance
|